2015 Match Sees High Proportion of Unmatched Seniors

Share this content:
2015 Match Sees High Proportion of Unmatched Seniors
2015 Match Sees High Proportion of Unmatched Seniors

(HealthDay News) -- About 6.1 percent of U.S. allopathic medical school seniors in the National Resident Matching Program (NRMP) were not placed into first-year residency positions, with a higher percentage of unmatched seniors than in 2014, according to a report published by the American Medical Association.

According to the NRMP, the 2015 Match included 41,334 total registrants, of whom 34,905 were active applications. An all-time high of 30,212 positions were offered in the 2015 Match. About three-quarters of applicants were matched into first-year positions. About 93.9 percent of the 18,025 active U.S. allopathic medical school seniors were matched into first-year programs. The match rate was about 79.3 percent for the nearly 3,000 osteopathic medical school students and graduates.

According to the report, more than half of the more than 600 new first-year positions were in primary care specialties, such as family medicine, internal medicine, and pediatrics. Internal medicine programs offered 6,770 positions, with 98.9 percent of positions filled, nearly half with U.S. seniors. Applicants who did not match to a residency program were offered unfilled positions; 1,193 of the 1,306 unfilled positions were offered during the NRMP Match Week Supplemental Offer and Acceptance Program.

"Medical education experts are concerned that the number of residency positions isn't keeping pace with growing medical school enrollment, prompting groups to release their ideas for how to strengthen the country's graduate medical education system," according to the article.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »